A Japanese single‐hospital observational trial with a retrospective case‐control analysis of varicella zoster virus reactivation after autologous peripheral blood stem cell transplantation
Authors:
- 3 June 2015
- journal article
- research article
- Published by Wiley in Transplant Infectious Disease
- Vol. 17 (4) , 544-550
Abstract
Background Varicella zoster virus (VZV) reactivation following hematopoietic stem cell transplantation (SCT) is common. To help reduce its incidence and to identify predictive factors for VZV reactivation after autologous SCT (auto‐SCT), we conducted a retrospective analysis in patients with hematologic malignancy at our hospital. Methods We conducted a single‐hospital observational trial with a retrospective case‐control analysis of post‐auto‐SCT VZV reactivation in patients with malignant lymphoma (ML) and multiple myeloma (MM) between January 2001 and December 2010, in the Department of Hematology at our hospital. First, we analyzed the cumulative incidence of VZV reactivation during the post‐SCT period. Second, we conducted a case‐control analysis to identify the risk factors for VZV reactivation within 1 year after SCT. Univariate analyses were performed using Fisher's exact test for categorical variables. A multivariable model and logistic regression were used to assess the risk factors for VZV reactivation. Results We included 97 patients in this study. The median duration of follow‐up was 1027 days. Forty‐two patients experienced VZV reactivation after SCT, while 29 (69.0%) experienced reactivation within 1 year after SCT. The cumulative incidence was 30.7% at 1 year and 51.2% for the total observation period. Multivariate analysis showed that engraftment after day 10 was an independent risk factor for VZV reactivation (P = 0.03). Conclusions Our study showed a high incidence of VZV reactivation in the first year after auto‐SCT in ML and MM patients. Patients with delayed engraftment are at high risk for VZV reactivation and should be considered for prolonged VZV prophylaxis.Keywords
This publication has 25 references indexed in Scilit:
- Incidence and Risk of Postherpetic Neuralgia after Varicella Zoster Virus Infection in Hematopoietic Cell Transplantation Recipients: Hokkaido Hematology Study GroupTransplantation and Cellular Therapy, 2009
- A Predictive Model of Varicella-Zoster Virus Infection after Autologous Peripheral Blood Progenitor Cell TransplantationClinical Infectious Diseases, 2001
- Varicella-zoster infection after allogeneic bone marrow transplantation: incidence, risk factors and prevention with low-dose aciclovir and ganciclovirBone Marrow Transplantation, 2000
- Varicella zoster virus infections following allogeneic bone marrow transplantation: Frequency, risk factors, and clinical outcomeTransplantation and Cellular Therapy, 2000
- Herpes zoster infection after bone marrow transplantation in childrenThe Journal of Pediatrics, 1996
- Herpes zoster in children with bone marrow transplantation: Report from a single institutionPediatrics International, 1995
- Herpes zoster infection after autologous bone marrow transplantationBlood, 1989
- Clinical and Subclinical Reactivations of Varicella-Zoster Virus in Immunocompromised PatientsThe Journal of Infectious Diseases, 1986
- Infection with Varicella-Zoster Virus After Marrow TransplantationThe Journal of Infectious Diseases, 1985
- VARICELLA-ZOSTER VIRUS INFECTION AFTER MARROW TRANSPLANTATION FOR APLASTIC ANEMIA OR LEUKEMIATransplantation, 1980